NCT07471789
- Conditions
- Acute Myeloblastic Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Hospital Clínic de Barcelona Barcelona, Spain
- Hospital Universitario y Politécnico La Fe Valencia, Spain
Clinical trial condition
Hematologic Diseases
Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.
15,364 public trials
2,842 recruiting studies
Hematologic Diseases trial results
NCT07218510
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
- City of Hope at Long Beach Elm Long Beach, California, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
Recruiting
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
NCT06260891
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
- Locations
-
- UCSF Benioff Children's Hospital Oakland Oakland, California, United States
- Duke University Medical Center Durham, North Carolina, United States
- Cincinnati Children's Hospital Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
NCT06348108
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Calfornia, San Francisco San Francisco, California, United States
Recruiting
Epcoritamab in Previously Treated WM
NCT06510491
- Conditions
- B-Cell Lymphoproliferative Disorder, Blood Protein Disorders, Cardiovascular Diseases, +14 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
NCT05451979
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Alberta Edmonton, Alberta, Canada
Recruiting
Elranatamab in R/R Multiple Myeloma
NCT06138275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT05735184
- Conditions
- AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, +19 more
- Locations
-
- Mayo Clinic - Phoenix Phoenix, Arizona, United States
- Moores UC San Diego Cancer Center La Jolla, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCLA - Bowyer Oncology Center Los Angeles, California, United States
NCT06142396
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +20 more
- Locations
-
- Georgia Cancer Center-Augusta University Augusta, Georgia, United States
NCT06867289
- Conditions
- Agnosia, Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- CHR Metz-Thionville Hopital Femme-Mère Enfant Metz, France